Free Trial

Equities Analysts Set Expectations for Amdocs Q3 Earnings

Amdocs logo with Computer and Technology background
Remove Ads

Amdocs Limited (NASDAQ:DOX - Free Report) - Stock analysts at Zacks Research reduced their Q3 2025 EPS estimates for shares of Amdocs in a research note issued on Tuesday, February 25th. Zacks Research analyst R. Department now expects that the technology company will earn $1.55 per share for the quarter, down from their previous forecast of $1.58. The consensus estimate for Amdocs' current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs' Q4 2025 earnings at $1.62 EPS, FY2025 earnings at $6.16 EPS, Q3 2026 earnings at $1.69 EPS, Q4 2026 earnings at $1.74 EPS, FY2026 earnings at $6.69 EPS and FY2027 earnings at $7.11 EPS.

Several other brokerages have also issued reports on DOX. Oppenheimer upped their price target on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday. Finally, Barclays dropped their price target on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, Amdocs has an average rating of "Moderate Buy" and an average price target of $101.20.

Read Our Latest Stock Analysis on DOX

Remove Ads

Amdocs Trading Down 0.4 %

NASDAQ:DOX traded down $0.34 during trading hours on Friday, hitting $86.48. 505,162 shares of the stock were exchanged, compared to its average volume of 662,991. The company has a market capitalization of $9.76 billion, a P/E ratio of 20.06, a price-to-earnings-growth ratio of 1.47 and a beta of 0.71. The company has a quick ratio of 1.20, a current ratio of 1.16 and a debt-to-equity ratio of 0.22. The company's 50 day moving average is $86.22 and its two-hundred day moving average is $86.86. Amdocs has a twelve month low of $74.41 and a twelve month high of $94.04.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a dividend of $0.527 per share. This is a positive change from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 annualized dividend and a yield of 2.44%. Amdocs's dividend payout ratio (DPR) is presently 48.72%.

Institutional Investors Weigh In On Amdocs

Several large investors have recently bought and sold shares of the company. Nordea Investment Management AB boosted its position in shares of Amdocs by 8.3% during the fourth quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company's stock worth $141,112,000 after purchasing an additional 127,426 shares in the last quarter. Mirabella Financial Services LLP lifted its holdings in Amdocs by 204.2% during the third quarter. Mirabella Financial Services LLP now owns 14,302 shares of the technology company's stock worth $1,250,000 after acquiring an additional 9,600 shares in the last quarter. Pacer Advisors Inc. grew its stake in Amdocs by 7.4% in the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock valued at $154,587,000 after acquiring an additional 125,654 shares during the period. Victory Capital Management Inc. grew its stake in Amdocs by 1.9% in the third quarter. Victory Capital Management Inc. now owns 478,137 shares of the technology company's stock valued at $41,827,000 after acquiring an additional 9,098 shares during the period. Finally, Crossmark Global Holdings Inc. increased its holdings in shares of Amdocs by 34.7% in the third quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company's stock worth $12,733,000 after acquiring an additional 37,516 shares in the last quarter. Institutional investors own 92.02% of the company's stock.

Amdocs Company Profile

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads